Avion Wealth’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
8
-8
| -50% | -$1K | ﹤0.01% | 1014 |
|
|
2025
Q1 | $2K | Hold |
16
| – | – | ﹤0.01% | 747 |
|
|
2024
Q4 | $2K | Sell |
16
-2
| -11% | -$250 | ﹤0.01% | 744 |
|
|
2024
Q3 | $2K | Sell |
18
-8
| -31% | -$889 | ﹤0.01% | 701 |
|
|
2024
Q2 | $3K | Buy |
26
+4
| +18% | +$462 | ﹤0.01% | 565 |
|
|
2024
Q1 | $4K | Buy |
22
+12
| +120% | +$2.18K | ﹤0.01% | 511 |
|
|
2023
Q4 | $1K | Sell |
10
-10
| -50% | -$1K | ﹤0.01% | 886 |
|
|
2023
Q3 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 503 |
|